Correlation Between Boston Scientific and Cytosorbents Crp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Scientific and Cytosorbents Crp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and Cytosorbents Crp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Scientific Corp and Cytosorbents Crp, you can compare the effects of market volatilities on Boston Scientific and Cytosorbents Crp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of Cytosorbents Crp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and Cytosorbents Crp.

Diversification Opportunities for Boston Scientific and Cytosorbents Crp

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Boston and Cytosorbents is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and Cytosorbents Crp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytosorbents Crp and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with Cytosorbents Crp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytosorbents Crp has no effect on the direction of Boston Scientific i.e., Boston Scientific and Cytosorbents Crp go up and down completely randomly.

Pair Corralation between Boston Scientific and Cytosorbents Crp

Considering the 90-day investment horizon Boston Scientific Corp is expected to generate 0.19 times more return on investment than Cytosorbents Crp. However, Boston Scientific Corp is 5.36 times less risky than Cytosorbents Crp. It trades about 0.19 of its potential returns per unit of risk. Cytosorbents Crp is currently generating about -0.03 per unit of risk. If you would invest  5,599  in Boston Scientific Corp on September 20, 2024 and sell it today you would earn a total of  3,444  from holding Boston Scientific Corp or generate 61.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Boston Scientific Corp  vs.  Cytosorbents Crp

 Performance 
       Timeline  
Boston Scientific Corp 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Cytosorbents Crp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cytosorbents Crp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Boston Scientific and Cytosorbents Crp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Scientific and Cytosorbents Crp

The main advantage of trading using opposite Boston Scientific and Cytosorbents Crp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, Cytosorbents Crp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will offset losses from the drop in Cytosorbents Crp's long position.
The idea behind Boston Scientific Corp and Cytosorbents Crp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators